You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
17 September 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) wants to hear your views on regulation of medical devices in the UK.
8 September 2021
New Zealand's Medicines Classification Committee (MCC) is set to reconsider an application to change the status of allopurinol for preventing gout, Europe’s Pharmacovigilance Risk Assessment Committee (PRAC) has extended the mandate of its vice chair for a further three years, and the UK’s Medicines...
19 August 2021
Reckitt’s Nuromol has become the first combination medicine containing ibuprofen and paracetamol to be allowed on general sale outside pharmacies in the UK. The company has been awarded one year of data exclusivity for studies carried out to support the switch from pharmacy (P) to general-sale list...
9 July 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for two oral contraceptive pills – HRA Pharma’s Hana and Maxwellia’s Lovima – to be sold without a prescription. Michelle Riddalls – chief executive officer of the Proprietary Association of Great Britain (PAG...
15 February 2021
Two applications to switch oral contraceptives from prescription-only to pharmacy (POM to P) status in the UK are now out for consultation. If they are approved, then Maxwellia’s Lovima and HRA Pharma’s Hana will become the country’s first OTC oral contraceptive pills.
31 December 2020
Sanofi’s Allevia – containing the antihistamine fexofenadine hydrochloride – has been switched from prescription-only to general sales list (GSL) status in the UK.
23 December 2020
The US Food and Drug Administration (FDA) has issued a number of warning letters to cannabidiol (CBD) companies, the Norwegian Medicines Agency (NoMA) is expanding the list of general-sale medicines, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued an exceptional us...
20 November 2020
Johnson & Johnson’s Benacort Hayfever Relief – containing the intranasal corticosteroid budesonide – has been switched to general-sales list (GSL) status in the UK.
23 September 2020
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced stronger warnings for prescribed and OTC medicines containing opioids, while New Zealand’s Medsafe is to reconsider a recent recommendation for pholcodine and has reached a settlement over Arthrem.
24 August 2020
New Zealand has set a date to reverse-switch codeine, while the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has a new chair and is backing a fire risk campaign for skin creams.